DATROWAY® (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0 ...
In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback